VI
HAE icon

Versor Investments’s Haemonetics HAE Stock Holding History

Versor Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,413
Closed -$459K – 676
2025
Q3 		$459K Buy
9,413
+6,410
+213% +$397K 0.08% 344
2025
Q2 		$224K Sell
3,003
-2,671
-47% -$177K 0.04% 631
2025
Q1 		$361K Buy
+5,674
New +$386K 0.06% 506
2024
Q4 		– Sell
-3,600
Closed -$289K – 844
2024
Q3 		$289K Buy
3,600
+300
+9% +$24.2K 0.05% 598
2024
Q2 		$273K Buy
+3,300
New +$290K 0.05% 552
2024
Q1 		– Sell
-7,921
Closed -$677K – 766
2023
Q4 		$677K Sell
7,921
-44
-0.6% -$3.8K 0.14% 233
2023
Q3 		$714K Buy
7,965
+3,639
+84% +$325K 0.14% 197
2023
Q2 		$368K Sell
4,326
-1,993
-32% -$169K 0.06% 356
2023
Q1 		$523K Sell
6,319
-5,281
-46% -$428K 0.07% 313
2022
Q4 		$912K Buy
11,600
+7,009
+153% +$563K 0.08% 171
2022
Q3 		$340K Buy
+4,591
New +$330K 0.02% 564
2019
Q1 		– Sell
-2,157
Closed -$216K – 291
2018
Q4 		$216K Sell
2,157
-2,600
-55% -$273K 0.05% 251
2018
Q3 		$545K Buy
4,757
+100
+2% +$10.4K 0.2% 145
2018
Q2 		$418K Hold
4,657
– – 0.14% 188
2018
Q1 		$341K Buy
+4,657
New +$320K 0.11% 196

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Versor Investments's HAE Position: Q4 2025 in Review

Versor Investments sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 9,413 shares — an estimated $459K sold.

Versor Investments first reported a position in HAE in Q1 2018 and held it in 15 quarters. The position peaked at $912K in Q4 2022. 329 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • Versor Investments reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • Versor Investments sold 9,413 Haemonetics shares in Q4 2025, an estimated $459K.
  • Versor Investments first reported a position in Haemonetics in Q1 2018 and held it in 15 quarters.
  • Versor Investments's Haemonetics position peaked at $912K in Q4 2022.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Versor Investments's 13F filing for Q4 2025, filed 4 Feb 2026.